# KitoTech Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kitotech-medical

- Industry: Medical Devices & Equipment
- Headquarters: Seattle, US
- Website: www.micromendskinclosure.com
- Latest round: Series A (Jun 1, 2018)
- Investors on record: 1

## About

KitoTech Medical, Inc. specializes in innovative wound closure solutions, particularly through its microMend product line, which combines technology for effective skin closure while promoting healing.Founded in 2011 in Seattle, US, KitoTech Medical, Inc. develops advanced wound closure devices. The company has raised a total of USD 2.00 mn through multiple funding rounds, with its latest being a Series B round on December 6, 2021. CEO Ronald Berenson leads the company, which focuses on commercializing microMend for various wound care applications.KitoTech Medical is primarily focused on the development and commercialization of microMend, an innovative wound closure device that utilizes a dual-action system comprising gentle, gripping Microstaples and Cantilever Springs. This product provides the holding strength equivalent to sutures while allowing for natural skin movement, which minimizes irritation and scarring at the wound site. microMend is designed for a wide range of applications, catering to both emergency situations and everyday injuries, making it especially suitable for use in pediatric care, as it eliminates the need for needles and traditional suturing methods. The company offers a variety of microMend products in multiple sizes to address nearly all types of wounds, ensuring accessibility for consumers. These products are marketed primarily in the United States and are intended for use by both healthcare professionals and individuals seeking effective wound care solutions for personal use.KitoTech Medical generates revenue through the direct sale of its microMend products, which are marketed to both healthcare providers and individual consumers. Transactions typically occur through retail channels, including both physical and online platforms, where customers can purchase individual packs or multi-device kits, such as the microMend Laceration Kit and the 2-in-1 Wound Repair Kit. The pricing structure of these products reflects their unique value proposition, with costs ranging based on the specific configuration and the number of devices included in each package. By offering a range of products that cater to different customer needs, KitoTech Medical supports a diverse client base that includes hospitals, clinics, and individual consumers, thereby establishing a broad market presence in the wound care sector.In December 2021, KitoTech Medical, Inc. raised approximately USD 2.00 mn in Series B funding to enhance its commercial efforts in the medical market, focusing on increasing the usage and sales of its microMend family of wound closure products. The company aims to expand its offerings with new products designed for broader applications in wound care. Plans for entering additional geographic markets are also in consideration, targeting expansion by 2023 to capture a larger share of the global wound care market.

## Funding rounds

- Series A, Jun 1, 2018 — Thynk Capital

## Investors

- Thynk Capital (https://capitalatlas.ai/funds/thynk-capital) — Series A